WeForNews | Latest News, Breaking News, News Updates Migrants, fishermen, senior citizen to gain from Cabinet decisions: PM Modi | WeForNews | Latest News, Blogs
Connect with us

Disaster

Migrants, fishermen, senior citizen to gain from Cabinet decisions: PM Modi

The Modi movement has set a target of 22 million metric tons by 2024-25 through sustainable and responsible fishing practices.

Published

on

Modi PM

New Delhi, May 20 : Prime Minister Narendra Modi on Wednesday said several decisions taken by the Cabinet today focused on welfare of migrants, poor and senior citizens, adding these would facilitate easier availability of credit and create opportunities in the fisheries sector.

While welcoming the Cabinet’s decision on formalisation of microfood processing enterprises, PM Modi tweeted: “The Cabinet decision will contribute to a vibrant food processing sector. It will also strengthen the efforts towards Atmanirbhar Bharat.”

The other schemes are expected to provide a big boost to the cooperatives & microfood businesses and ensure adequate livelihood for rural-urban communities.

On ‘Pradhan Mantri Matsya Sampada Yojana’, Modi said it will “revolutionise the fisheries sector”. “It will invigorate it with latest technology, infrastructure and ensure financial assistance. Our hardworking fishermen will gain immensely,” the PM tweeted.

The Union Cabinet, chaired by the Prime Minister Modi has given its approval for implementation of the scheme that is expected to bring about Blue Revolution through sustainable and responsible development of fisheries sector in India under two components — Central Sector Scheme and Centrally Sponsored Scheme — at a total estimated investment of Rs 20,050 crore.

The scheme is likely to address the critical gaps in the fisheries sector and realize its potential apart from creation of direct gainful employment opportunities to about 15 lakh fishers, fish farmers, fish workers and fish vendors.

The Modi movement has set a target of 22 million metric tons by 2024-25 through sustainable and responsible fishing practices.

Cities

Earthquake of magnitude 4.1 strikes Jammu and Kashmir

They said while the tremors caused panic among people, there were no reports of any loss of life or injury or damage to property.

Published

on

Earthquake Strong

Srinagar, Jan 16 : An earthquake of magnitude 4.1 hit Jammu and Kashmir on Saturday, but there was no report of any damage, officials said.

At 10:01 pm, the earthquake struck at a latitude of 33.03 degrees north and a longitude of 75.93 degrees east — 93 kms east of Katra, they added.

The depth of the earthquake was 10 kms, the officials said.

They said while the tremors caused panic among people, there were no reports of any loss of life or injury or damage to property.

Continue Reading

Blog

Covaxin consent form says vax administered without ph-3 trial

The vaccine is first offered to the healthcare workers, frontline workers and those above 50 years of age, followed by the below-50 population with comorbidities, and finally to the remaining population based on disease epidemiology and vaccine availability.

Published

on

By

COVAXIN Corona Covid vaccine

New Delhi, Jan 16 : Amid the vaccinaton drive against Covid-19, it has emerged that there is a separate consent form for those who are administered the ‘Covaxin‘ vaccine manufactured by Bharat Biotech.

The form says that “In phase-1 and phase-2 clinical trial ‘Covaxin’ has demonstrated the ability to produce antibodies against Covid-19, however the clinical efficacy of Covaxin is yet to be established and it is still being studied in phase-3 clinical trial, hence it is important to appreciate that receiving the vaccine does not mean that the other precautions related to Covid-19 should not be followed.”

The form says that in case of any adverse and serious condition, the receiver will be provided utmost care at the health centre and in case of casuality the compensation will be provided by Bharat Biotech.

“The compensation for serious adverse event will be paid by sponsor BBIL if the SAE is proven to be casually related to the vaccine,” it said.

Serious concerns were raised in certain quarters including by opposition parties and Congress leader Manish Tewari has questioned the efficacy of ‘Covaxin’ while the Prime Minister has warned people not to believe in “rumours”.

The world’s biggest vaccination drive come almost a year after the first coronavirus case was detected in India, and since then the deadly virus has claimed over 1.5 lakh lives and infected one crore people. The first case came to the fore on January 30, 2020 in Kerala.

Two vaccines — the Oxford vaccine ‘Covishield’ manufactured by the Serum Institute of India, and indigenously developed ‘Covaxin’ by Bharat Biotech — will be administered to priority groups. So far, the central government has procured 1.1 crore Covishield and 55 lakh Covaxin vaccines at a cost of Rs 200 and Rs 206 per dose, respectively.

In Delhi, which has 81 vaccination sites, ‘Covaxin’ has been allotted to six Centre-run hospitals while 75 Delhi government and private hospitals will receive ‘Covishield’.

The vaccine is first offered to the healthcare workers, frontline workers and those above 50 years of age, followed by the below-50 population with comorbidities, and finally to the remaining population based on disease epidemiology and vaccine availability.

Continue Reading

Disaster

Magnitude 6.7 Earthquake Hits Russia-Mongolia Border Region

The quake was at a depth of 10 kilometers

Published

on

Earthquake Strong

AN earthquake of magnitude 6.7 struck the Russia-Mongolia Border Region on Tuesday, the GFZ German Research Center for Geosciences said.

The quake was at a depth of 10 kilometers, it added.

The epicenter of the earthquake was registered 277 kilometers southwest of the city of Angarsk, in the Russian Irkutsk region, and 30 kilometers from the Mongolian city of Turt, Russian state-owned news agency Sputnik reported. https://bit.ly/2XtgrJs

There were no immediate reports of damage or victims, the report said.

Continue Reading
Advertisement

Most Popular